InfuSystem Holdings (INFU) Amortization of Deferred Charges (2010 - 2026)
InfuSystem Holdings (INFU) posted Amortization of Deferred Charges of $21000.0 for Q1 2026, up 5.0% on a QoQ basis from $20000.0 in Q4 2025, and up 10.53% year-over-year from $19000.0 in Q1 2025.
InfuSystem Holdings (INFU) Amortization of Deferred Charges (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Amortization of Deferred Charges history runs 11 years deep, the most recent figure standing at $21000.0 for Q1 2026.
- Quarterly Amortization of Deferred Charges rose 10.53% year-over-year to $21000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $83000.0 (up 6.41% YoY) and the FY2025 annual result came in at $81000.0, up 3.85% from the prior year.
- Amortization of Deferred Charges was $21000.0 for Q1 2026 at InfuSystem Holdings, up from $20000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $60000.0 in Q2 2023 and bottomed at $18000.0 in Q1 2022.
- A 5-year average of $21941.2 and a median of $20000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges slumped 81.25% — and 2023, when it soared 215.79%.
- InfuSystem Holdings' Amortization of Deferred Charges stood at $18000.0 in 2022, then advanced by 16.67% to $21000.0 in 2023, then declined by 4.76% to $20000.0 in 2024, then changed by 0.0% to $20000.0 in 2025, then climbed by 5.0% to $21000.0 in 2026.
- Business Quant data shows INFU's Amortization of Deferred Charges at $21000.0 in Q1 2026, $20000.0 in Q4 2025, and $22000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn |
| 10 | InfuSystem Holdings | 188.77 Mn | 186.67 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Dec 31, 2023 | 21,000.00 |